Guidelines And Criteria [iPhone]

American College of Rheumatologyが配信するiPhoneアプリ「Guidelines And Criteria」の評価や口コミやランキング推移情報です。このアプリには「メディカル」「ヘルスケア/フィットネス」などのジャンルで分類しています。APPLIONでは「Guidelines And Criteria」の他にもあなたにおすすめのアプリのレビューやみんなの評価や世界ランキングなどから探すことができます。

Guidelines And Criteria

American College of Rheumatology 無料 iPhone / iPad対応メディカルヘルスケア/フィットネス 64bit

Trend

AppStoreでチェック！

American College of Rheumatologyのメディカル系アプリ

「Guidelines And Criteria」は、American College of Rheumatologyが配信するメディカル系アプリです。

メディカルヘルスケア/フィットネス

このアプリの話題とニュース

新バージョン1.6が配信開始。新機能や改善アップデートがされています。
2019年7月1日(月)にiPhoneとiPad両対応のユニバーサルアプリとしてリリース！

使い方や遊び方

The American College of Rheumatology’s Guideline and Criteria App is the go-to tool for implementing guideline recommendations and criteria sets into practice. Free to both members and non-members, this app is ACR’s mobile home for tools and content for clinicians caring for patients with rheumatic diseases. App features include: interactive tools to inform treatment decisions at the point of care, including algorithms, score and calculators; full guideline and criteria content; keyword searches; customizable bookmarks; and note-taking capabilities.

Current guidelines and criteria in the app include:

· Guideline for the Treatment of Rheumatoid Arthritis
· Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
· Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic

Diseases Undergoing Total Hip or Knee Arthroplasty
· Guideline for Treatment of Psoriatic Arthritis
· Rheumatoid Arthritis Classification Criteria
· Systemic Sclerosis Classification Criteria
· Gout Classification Criteria
· Sjogren’s Syndrome Classification Criteria
· Myositis Classification Criteria

Stay tuned for ongoing updates, as well as new guideline and criteria tools and content.

Send feedback to the ACR directly from the App Information page or post a review in the App Store.
Help us find new and better ways to deliver guideline and criteria content to clinicians.